JIM
IART icon

Jupiter Investment Management’s Integra LifeSciences IART Stock Holding History

Jupiter Investment Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-16,721
Closed -$704K – 437
2017
Q1 		$704K Buy
+16,721
New +$714K 0.01% 263

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jupiter Investment Management's IART Position: Q2 2017 in Review

Jupiter Investment Management sold out of Integra LifeSciences (IART) in Q2 2017, closing a stake of 16,721 shares — an estimated $704K sold.

Jupiter Investment Management first reported a position in IART in Q1 2017 and held it in 1 quarter. The position peaked at $704K in Q1 2017. 223 funds tracked by Wall St. Rank hold IART as of Q2 2017.

  • Jupiter Investment Management reported no remaining Integra LifeSciences position as of Q2 2017 after selling out during the quarter.
  • Jupiter Investment Management sold 16,721 Integra LifeSciences shares in Q2 2017, an estimated $704K.
  • Jupiter Investment Management first reported a position in Integra LifeSciences in Q1 2017 and held it in 1 quarter.
  • Jupiter Investment Management's Integra LifeSciences position peaked at $704K in Q1 2017.
  • 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2017.

Based on Jupiter Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.